Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts

The summary for the Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts: The primary purpose of this opportunity is to fund applicants with existing access to adult lupus patient populations and can extend current knowledge over 12-17 years from baseline. A second component of this funding opportunity will focus on the pediatric lupus - to advance existing knowledge of lupus in pediatric populations using an existing cohort of lupus patients. Because lupus is a rare condition, it is efficient to obtain new information from existing relevant cohorts with lupus. The research objectives among both adult and pediatric populations are to: Examine the treatment (e.g., medications including opioid; type; appropriateness; etc.) of people with lupus. Determine health care access and gaps that people with lupus experience in addressing their varied health problems (e.g., general health problems as well as those for specific lupus outcomes, such as nephritis; transitions to adulthood). Determine longer term natural history (severity, chronic pain, progression, morbidity, mortality, disability and quality of life, work/ school/activity interference, etc.) of people with lupus, including assessing potential genetic factors. Examine other factors related to disparities in lupus outcomes (e.g., age, sex, and race/ethnic group). Examine lupus comorbidities.

Federal Grant Title:	Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DP-22-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.068
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 19th, 2022
Original Application Deadline:	January 19th, 2022
Posted Date:	November 4th, 2021
Creation Date:	November 4th, 2021
Archive Date:	February 18th, 2022
Total Program Funding:	$26,400,000
Maximum Federal Grant Award:	$900,000
Minimum Federal Grant Award:	$870,000
Expected Number of Awards:	6
Cost Sharing or Matching:	No
Last Updated:	January 6th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Special Eligibility. For an application to be considered, the application must be responsive to these Special Eligibility Requirements. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component A: Epidemiology of Lupus Among the Adults Applicants must have access to an existing and established baseline cohort of lupus patients that has been followed for at least 5 years. The sample size of the cohort to be used for this study should include a minimum of 400 lupus participants. If an applicant requests a funding amount greater than the ceiling of $900,000 (Section II. Award Information) for either Component (A or B) as indicated in Section II of this NOFO, HHS/CDC will consider the application non-responsive, and it will not enter into the review process. HHS/CDC will notify the applicant that the application did not meet the submission requirement. Component B: Epidemiology of Lupus in the Pediatric Population Applicants must have access to an existing and established baseline cohort of lupus patients that has been followed for at least 3 years. The sample size of the cohort to be used for this study should include a minimum of 400 lupus participants. If an applicant requests a funding amount greater than the ceiling of $900,000 (Section II. Award Information) for either Component (A or B) as indicated in Section II of this NOFO, HHS/CDC will consider the application non-responsive, and it will not enter into the review process. HHS/CDC will notify the applicant that the application did not meet the submission requirement.
Grant Announcement Contact: Sue Shaw
[email protected]
[email protected]
Similar Government Grants: • Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations ...; • PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determi...; • PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Diabetes Prevention and Control in the Americas; • Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease ...; • Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth ...
More Grants from the Centers for Disease Control and Prevention ERA: • Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexu...; • Formative Research of Community-led Primary Prevention Approaches to Address Elevated Risk...; • Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populati...; • Effectiveness Research to Prevent Polysubstance-Impaired Driving; • Grants to Support New Investigators in Conducting Research Related to Preventing Interpers...